Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-04

Clinical Trial Update: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

View source ↗

Summary

A clinical trial evaluating the PlasmaButton Vaporization Electrode for symptomatic benign prostatic hyperplasia in patients on anticoagulant therapy has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PlasmaButton Vaporization Electrode

Snippet

Sponsor: Olympus Corporation of the Americas | Conditions: Benign Prostatic Hyperplasia | Status: TERMINATED